As of Feb 26
| +0.72 / +1.99%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 41.50, with a high estimate of 47.00 and a low estimate of 40.00. The median estimate represents a +12.53% increase from the last price of 36.88.
The current consensus among 5 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.